Dietary antioxidants improve arteriogenic erectile dysfunction

International Journal of Andrology

Volumn 34, Issue 3, 2011, Pages 225-235

  Zhang, Q ^a   Radisavljevic, Z M ^a   Siroky, M B ^a   Azadzoi, K M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Erectile dysfunction; Ischaemia; Oxidative stress

Indexed keywords

ALDEHYDE REDUCTASE; ANTIOXIDANT; DRINKING WATER; POMEGRANATE EXTRACT; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CAVEOLA; CONTROLLED STUDY; DIETARY INTAKE; ENDOTHELIUM; ERECTILE DYSFUNCTION; FIBROSIS; GENE EXPRESSION; ILIAC ARTERY; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PENILE BLOOD FLOW; PENIS ERECTION; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE RELAXATION;

ALDEHYDE REDUCTASE; ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; EATING; ERECTILE DYSFUNCTION; GENE EXPRESSION REGULATION; IMPOTENCE, VASCULOGENIC; ISCHEMIA; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; OXIDATIVE STRESS; PENIS; PLANT EXTRACTS; PUNICACEAE; RABBITS; SUPEROXIDE DISMUTASE;

EID: 79955579571     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2010.01083.x     Document Type: Article

References (35)

1. Aragno M, Cutrin JC, Mastrocola R, Perrelli MG, Restivo F, Poli G, Danni O & Boccuzzi G. (2003) Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. Kidney Int 64, 836-843.
2. Aviram M & Dornfeld L. (2001) Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158, 195-198.
3. Aviram M, Dorenfeld L, Rosenblat M, Volkova N, Kaplan M, Hayek T et al. (2000) Pomegranate juice consumption reduces oxidative stress, low density lipoprotein modifications and platelet aggregation: studies in the atherosclerotic apolipoprotein E deficient mice and in humans. Am J Clin Nutr 71, 1062-1076.
4. Aydos K, Baltacia S, Sajlam M, Tanyola A, Anafarta K, Bedok Y et al. (1996) Ultrastructual changes of corpora cavemosa in vascular erectile dysfunction. Int Urol Nephrol 28, 375-385.
5. Azadzoi KM, Kim N, Brown ML, Goldstein I, Cohen RA & Saenz de Tejada I. (1992) Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. J Urol 147, 220-225.
6. Azadzoi KM, Goldstein I, Siroky MB, Krane RJ, Traish A & Saenz de Tejada I. (1998) Mechanism of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol 160, 2216-2222.
7. Azadzoi KM, Master TA & Siroky MB. (2004) Effect of chronic ischemia on constitutive and inducible nitric oxide synthase expression in erectile tissue. J Androl 25, 382-388.
8. Azadzoi KM, Schulman R, Michael A & Siroky MB. (2005) Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. J Urol 174, 386-393.
9. Barassi A, Colpi GM, Piediferro G, Dogliotti G, D'Eril GV & Corsi MM. (2009) Oxidative stress and antioxidant status in patients with erectile dysfunction. J Sex Med 6, 2820-2825.
10. Bello-Klein A, Bock PM, Travacio M, Senna SM, Llesuy S, de Bittencourt PI et al. (2001) Myocardial oxidative stress and antioxidants in hypertension as a result of nitric oxide synthase inhibition. Cardiovasc Toxicol 1, 43-50.
11. Blinova K, Levine RL, Boja ES, Griffiths GL, Shi ZD, Ruddy B & Balaban RS. (2008) Mitochondrial NADH fluorescence is enhanced by complex I binding. Biochemistry 47, 9636-9645.
12. Corona G, Mannucci E, Mansani R, Petrone L, Bartolin M, Giommi R et al. (2004) Aging and pathogenesis of erectile dysfunction. Int J Impot Res 16, 395-402.
13. Fanfulla F, Malaguti S, Montagna T, Salvini S, Bruschi C, Crotti P et al. (2000) Erectile dysfunction in men with obstructive sleep apnea: an early sign of nerve involvement. Sleep 23, 775-781.
14. Fernández-Arjona M, Díaz J, Carbonell L, Oteros R, Zarca MA & Cortés I. (2001) Antioxidative state and lipid peroxidation in erectile dysfunction: preliminary study. Arch Esp Urol 54, 361-366.
15. Fuhrman B, Lavy A & Aviram M. (1995) Consumption of red wine with meals reduces the susceptibility of human plasma and LDL to undergo lipid peroxidation. Am J Clin Nutr 61, 549-554.
16. Grein U & Schubert GE. (2002) Arteriosclerosis of penile arteries: histological findings and their significance in the treatment of erectile dysfunction. Urol Int 68, 261-264.
17. Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R et al. (1997) Reduced progression of atherosclerosis in the apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin, or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 17, 2744-2752.
18. Helmut S. (2005) Strategies of antioxidant defense. Eur J Biochem 215, 213-219.
19. Kim N, Azadzoi KM, Goldstein I & Saenz de Tejada I. (1991) A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest 88, 112-118.
20. Kinlay S, Behrendt D, Fang JC, Delagrange D, Morrow J, Witztum JL et al. (2004) Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol 43, 629-634.
21. Kloner RA, Mullin SH, Shook T, Mayeda G, Burstein S et al. (2003) Erectile dysfunction in the cardiac patient: how common and should we treat it? J Urol 170, S46-S50.
22. Krane RJ, Goldstein I & Saenz de Tejada I. (1989). Impotence. N Engl J Med 321, 1648-1659.
23. Ortiz MC, Manriquez MC, Romero JC & Juncos LA. (2001) Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension 38, 655-659.
24. Peixoto E, Pessoa B, Biswas S & Lopes de Faria J. (2009) Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol 29, 309-318.
25. Qutub AA & Popel AS. (2008) Reactive oxygen species regulate hypoxia-inducible factor 1 differentially in cancer and ischemia. Mol Cell Biol 28, 5106-5119.
26. Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ & Weyand CM. (1999) Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest 103, 1007-1013.
27. Ryu JK, Han JY, Chu YC, Song SU, Lee KH, Yoon SM, Suh JK & Kim SJ. (2004) Expression of cavernous transforming growth factor-beta1 and its type II receptor in patients with erectile dysfunction. Int J Androl 27, 42-49.
28. Saenz de Tejada I, Blanco R, Goldstein I, Azadzoi KM, Morenas A, Krane RJ & Cohen RA. (1988) Cholinergic neurotransmission in human corpus cavernosum. I: responses of isolated tissue. Am J Physiol 254 ( Heart Circ Physiol 23 ), H459-H467.
29. Serefoglu EC, Erdamar H, Ozdemir AT, Atmaca AF, Berktas M & Balbay MD. (2009) Penile blood cyclic guanosin monophosphate level is associated with penile Doppler ultrasound findings. Int J Impot Res 21, 51-56.
30. Siroky MB & Azadzoi KM. (2003) Vasculogenic erectile dysfunction: newer therapeutic strategies. J Urol 170, S24-S30.
31. Siroky MB & Azadzoi KM. (2004) Male and female sexual dysfunction. In: Pelvic Floor Disorders (ed. Bourcier, McGuire and Abrams), chapter 13, pp. 89-120. Elsevier Saunders, Philadelphia, PA, USA.
32. Solomon H, Man JW & Jackson G. (2003) Erectile dysfunction and the cardiovascular patient. Heart 89, 251-253.
33. Tostes RC, Carneiro FS, Lee AJ, Giachini FR, Leite R, Osawa Y & Webb RC. (2008) Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation. J Sex Med 5, 1284-1295.
34. Voss P & Siems W. (2006) Clinical oxidation parameters of aging. Free Radic Res 40, 1339-1349.
35. Yulia S, Petter H & Karl S. (2009) Impaired nerve-mediated relaxation of penile tissue from caveolin-1 deficient mice. Eur J Pharmacol 602, 399-405.